Online citations, reference lists, and bibliographies.
← Back to Search

Reactive Metabolites In The Biotransformation Of Molecules Containing A Furan Ring.

L. Peterson
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Many xenobiotics containing a furan ring are toxic and/or carcinogenic. The harmful effects of these compounds require furan ring oxidation. This reaction generates an electrophilic intermediate. Depending on the furan ring substituents, the intermediate is either an epoxide or a cis-enedione with more ring substitution favoring epoxide formation. Either intermediate reacts with cellular nucleophiles such as protein or DNA to trigger toxicities. The reactivity of the metabolite determines which cellular nucleophiles are targeted. The toxicity of a particular furan is also influenced by the presence of competing metabolic pathways or efficient detoxification routes. GSH plays an important role in modulating the harmful effects of this class of compound by reacting with the reactive metabolite. However, this may not represent a detoxification step in all cases.
This paper references
Vapor phase analysis of tobacco smoke
R J. (1965)
Vapor phase analysis of tobacco smoke
R J. (1965)
10.1038/2141166b0
Adverse Reactions
N. Bolton (1967)
10.3109/15563657308991049
Effects of exposure to solvents caused by air pollution with special reference to CCl 4 and its distribution in air.
P. Capurro (1973)
10.1038/251508A0
Hepatic necrosis caused by furosemide
Jerry R. Mitchell (1974)
10.1016/0005-2760(74)90200-8
Lung-toxic furanoterpenoids produced by sweet potatoes (Ipomoea batatas) following microbial infection.
M. Boyd (1974)
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite.
J. R. Mitchell (1976)
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite
D. J. Jollow (1976)
In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol.
M. Boyd (1978)
10.1038/272270A0
Pulmonary bronchiolar alkylation and necrosis by 3-methylfuran, a naturally occurring potential atmospheric contaminant
M. Boyd (1978)
10.1001/JAMA.1979.03300260043027
Pennyroyal oil poisoning and hepatotoxicity.
J. B. Sullivan (1979)
Biotransformation of furosemide in patients with acute pulmonary edema.
J. Perez (1979)
10.1016/0006-291X(80)90612-9
Comparison of ratios of covalent binding to total metabolism of the pulmonary toxin, 4-ipomeanol, in vitro in pulmonary and hepatic microsomes, and the effects of pretreatments with phenobarbital or 3-methylcholanthrene.
M. Boyd (1980)
The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.
A. Buckpitt (1980)
The in vitro formation
A. R. Buckpitt (1980)
10.1016/0006-2952(82)90643-8
Effects of phenobarbital and 3-methylcholanthrene on the in vivo distribution, metabolism and covalent binding of 4-ipomeanol in the rat; implications for target organ toxicity.
C. Statham (1982)
10.1016/0041-008X(82)90387-8
Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse.
W. P. Gordon (1982)
The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
C. R. Wolf (1982)
Effects of phenobarbitol
C. N. Statham (1982)
10.1016/0014-4800(83)90063-1
Pathology of acute inhalation exposure to 3-methylfuran in the rat and hamster.
W. Haschek (1983)
10.1016/0300-483X(84)90091-X
The effect of 3-methylfuran inhalation exposure on the rat nasal cavity.
C. C. Morse (1984)
10.1016/0041-008X(84)90256-4
Acute inhalation toxicity of 3-methylfuran in the mouse: pathology, cell kinetics, and respiratory rate effects.
W. Haschek (1984)
10.1016/0300-483X(84)90128-8
Toxicity-distribution relationships among 3-alkylfurans in the mouse lung.
L. Gammal (1984)
10.1016/0041-008X(84)90263-1
Toxicity-distribution relationships among 3-alkylfurans in mouse liver and kidney.
R. Wiley (1984)
10.1016/0041-008X(85)90242-X
Metabolic activation of 2-methylfuran by rat microsomal systems.
V. Ravindranath (1985)
Pulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice.
S. Durham (1985)
10.1080/15287398509530765
Long-term effects of repeated exposure to 3-methylfuran in hamsters and mice.
H. Witschi (1985)
Furans, in Bioactivation of Foreign Compounds, pp 243−257
L. T. Burka (1985)
10.1002/em.2860080702
Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
K. Mortelmans (1986)
10.1016/0300-483X(87)90005-9
Furosemide toxicity in isolated mouse hepatocyte suspensions.
T. Massey (1987)
The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
W. P. Gordon (1987)
Activated oncogenes
S. A. Aaronson (1987)
Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course.
D. Thomassen (1988)
Acute Inhalation Toxicity of Saxitoxin to Mice
D. A. Cresia (1988)
10.3109/00498258909034694
Metabolism of a monoterpene ketone, R-(+)-pulegone--a hepatotoxin in rat.
B. Moorthy (1989)
10.1021/TX00011A013
Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins.
R. H. Mcclanahan (1989)
Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
D. Thomassen (1990)
10.1016/S0006-291X(05)80897-6
Biotransformations of R-(+)-pulegone and menthofuran in vitro: chemical basis for toxicity.
K. M. Madyastha (1990)
10.1080/15287399109531564
Disposition of [14C]furan in the male F344 rat.
L. Burka (1991)
Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism.
M. Czerwiński (1991)
Effect of modulations
V. Ravindranath (1991)
10.7326/0003-4819-117-2-129
Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity.
D. Larrey (1992)
[Acute hepatitis caused by wild germander. Hepatotoxicity of herbal remedies. Two cases].
A. Pauwels (1992)
[Liver damage induced by the ingestion of a product of phytotherapy containing wild germander. Four cases].
A. Mattei (1992)
[Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance].
A. Castot (1992)
10.1002/EM.2850190305
Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan
D. M. Wilson (1992)
10.1016/0140-6736(92)92209-X
Fatal hepatitis after herbal tea
N. Mostefa-Kara (1992)
[Cytolytic hepatitis and wild Germander: a new case with reintroduction].
J. Legoux (1992)
10.1021/JO00035A040
Evidence for the formation of heterocyclic arene oxides and a γ-keto enal by reaction of menthofuran with dimethyldioxirane
Shimako Oishi (1992)
10.1002/CHIN.199216112
Oxidation of Furans with Dimethyldioxirane.
B. Adger (1992)
[Fulminant hepatitis caused by wild germander].
David Martínez Díaz (1992)
10.1021/TX00025A021
Reactive intermediates in the oxidation of menthofuran by cytochromes P-450.
D. Thomassen (1992)
Metabolic fate of menthofuran in rats. Novel oxidative pathways.
K. M. Madyastha (1992)
Metabolic fate
K. M. Madyastha (1992)
Acute hepatitis caused by wild
M. Biour (1992)
Hepatitis observed during
A. Castot (1992)
Liver damage induced by the
M. Chevallier (1992)
Hepatitis after germander (Teucrium
H. Michel (1992)
[Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].
M. Ben Yahia (1993)
10.1002/JBT.2570080103
Studies on the interaction of furan with hepatic cytochrome P-450.
D. Parmar (1993)
10.1006/TAAP.1993.1237
CYP4B1 activates 4-ipomeanol in rat lung.
R. Verschoyle (1993)
10.1006/TAAP.1993.1246
Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro.
G. L. Kedderis (1993)
10.1177/074823379300900303
Liver Carcinogenesis is Not a Predicted Outcome of Chemically Induced Hepatocyte Proliferation
Ronald L. Melnick (1993)
10.1016/0169-5002(94)90879-6
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
E. Rowinsky (1993)
Phase I and pharmacological study
R. C. Donehower (1993)
10.1016/0300-483X(94)90220-8
Effects of menthofuran, a monoterpene furan on rat liver microsomal enzymes, in vivo.
K. M. Madyastha (1994)
10.1016/0016-5085(94)90606-8
Hepatotoxicity of germander in mice.
J. Loeper (1994)
10.1021/TX00042A020
Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse.
S. Kouzi (1994)
Effects of menthofuran
K. M. Madyastha (1994)
Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor.
M. Chiba (1995)
Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
N. Chauret (1995)
Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeys.
J. Lin (1995)
10.1177/019262339602400113
Biliary Proliferation and Adaptation in Furan-Induced Rat Liver Injury and Carcinogenesis
A. Sirica (1996)
10.1002/HEP.510240134
Hepatotoxicity of the herbal medicine germander: Metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton‐associated protein thiols and forms plasma membrane blebs in rat hepatocytes
M. Lekehal (1996)
10.1021/TX960060B
In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
Y. Sahali-Sahly (1996)
Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
D. Edwards (1996)
10.1021/TX950183G
Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation.
K. Zhang (1996)
10.1139/Y96-019
Bromobenzene and furosemide hepatotoxicity: alterations in glutathione, protein thiols, and calcium.
K. K. Grewal (1996)
10.7326/0003-4819-124-8-199604150-00004
Pennyroyal Toxicity: Measurement of Toxic Metabolite Levels in Two Cases and Review of the Literature
I. Anderson (1996)
10.1177/019262339602400211
Lipidosis Induced in the Dog Gallbladder by a Direct 5-Lipoxygenase Inhibitor
S. Molon-Noblot (1996)
10.1016/S0300-483X(97)03618-4
Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice.
R. Fransson-Steen (1997)
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
P. Schmiedlin-Ren (1997)
Mechanisms of enhanced
P. F. Hollenberg (1997)
Mechanisms of enhanced
P. F. Hollenberg (1997)
10.1021/TX970192K
Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice.
K. He (1998)
10.1007/978-3-642-72117-5_18
Induction and Progression of Somatic Embryogenesis
F. L. Schiavo (1998)
10.1021/BI981280M
Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1.
Y. Zheng (1998)
(R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.
S. Khojasteh-Bakht (1998)
10.1046/J.1365-2125.1998.00679.X
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
V. Eagling (1998)
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
V. K. Kasturi (1998)
10.1080/004982598239146
Metabolic fate of S-(-)-pulegone in rat.
K. M. Madyastha (1998)
R)-(+)-Menthofuran is a potent
S. D. Nelson (1998)
R)-(+)-Menthofuran is a potent
S. D. Nelson (1998)
Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.
S. Khojasteh-Bakht (1999)
10.1021/TX9900019
Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
R. L. Moreno (1999)
10.1016/S0378-4274(00)00218-6
The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity.
S. Wong (2000)
10.1021/BI992412U
Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394.
L. Lightning (2000)
Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
L. Q. Guo (2000)
10.1124/MOL.58.3.542
Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes.
V. de Berardinis (2000)
10.1006/ABBI.2000.1835
Inhibition selectivity of grapefruit juice components on human cytochromes P450.
W. Tassaneeyakul (2000)
Human microsomal epoxide
D. Pompon (2000)
Human microsomal epoxide
D. Pompon (2000)
10.1021/JA0056421
Reaction of cis- and trans-2-Butene-1,4-dial with 2'-deoxycytidine to form stable oxadiazabicyclooctaimine adducts.
L. Gingipalli (2001)
10.1021/TX015574B
Biotransformation reactions of five-membered aromatic heterocyclic rings.
D. Dalvie (2002)
Integration of clinical and genetic information - from patient data to gene expression analysis
M. Dugas (2002)
10.1080/20024091064273
Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung
J. Hukkanen (2002)
10.1289/EHP.02110689
Volatile organic compounds as breath biomarkers for active and passive smoking.
S. Gordon (2002)
10.1007/s00228-002-0537-3
Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel
H. Wangensteen (2003)
10.1124/DMD.31.10.1208
Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites.
L. Chen (2003)
10.1021/TX049866Z
The formation of substituted 1,N6-etheno-2'-deoxyadenosine and 1,N2-etheno-2'-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan.
Michael C. Byrns (2004)
10.1007/BF00607581
The urinary excretion of frusemide and its metabolites by kidney transplant patients
H. Nakahama (2004)
10.1023/A:1006408803734
Phase II Study of 4-Ipomeanol, a Naturally Occurring Alkylating Furan, in Patients with Advanced Hepatocellular Carcinoma
S. Lakhanpal (2004)
10.1021/TX0498861
Detection of covalent adducts to cytochrome P450 3A4 using liquid chromatography mass spectrometry.
K. Bateman (2004)
10.1124/dmd.104.000406
DETECTION OF GLUTATHIONE CONJUGATES DERIVED FROM 4-IPOMEANOL METABOLISM IN BILE OF RATS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
T. Alvarez-Diez (2004)
10.1016/j.lfs.2003.09.035
Herbal bioactivation: The good, the bad and the ugly
Shufeng Zhou (2004)
10.1007/BF00613429
On the fate of furosemide in man
B. Beermann (2004)
10.1021/TX034143L
Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol.
T. Alvarez-Diez (2004)
THE NATURALLY OCCURRING CYTOCHROME P 450 ( P 450 ) 2 B 6 K 262 R MUTANT OF P 450 2 B 6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
Namandjé N. Bumpus (2005)
10.1021/TX0496993
Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate.
Brian R. Baer (2005)
10.1124/JPET.104.079608
The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5
H. Lin (2005)
10.1021/TX060111X
Identification of a cis-2-butene-1,4-dial-derived glutathione conjugate in the urine of furan-treated rats.
L. Peterson (2006)
10.1124/jpet.105.099887
Metabolism of Bergamottin by Cytochromes P450 2B6 and 3A5
U. Kent (2006)
10.1021/TX060128F
Metabolism of furans in vitro: ipomeanine and 4-ipomeanol.
Ling-Jen Chen (2006)
10.1021/TX050302K
Detection of DNA adducts derived from the reactive metabolite of furan, cis-2-butene-1,4-dial.
Michael C. Byrns (2006)
METABOLISM OF PRAZOSIN IN RAT , DOG AND HUMAN LIVER MICROSOMES AND CRYOPRESERVED RAT AND HUMAN HEPATOCYTES AND CHARACTERIZATION OF METABOLITES BY LC / MS / MS
J. Erve (2007)
10.1021/TX7001405
Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat.
Alexandra Drucková (2007)
IDENTIFICATION OF VOLATILE COMPOUNDS IN SOY SAUCE
Huang Xiao-lan (2007)
10.1021/TX060234H
Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
N. Masubuchi (2007)
10.1124/jpet.107.125302
The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore
D. Williams (2007)
10.1021/TX700262Z
Chemical and enzymatic oxidation of furosemide: formation of pyridinium salts.
Ling-Jen Chen (2007)
reactive intermediates and in vitro glutathione conjugate formation in rats and humans
L. J. Chen (2007)
10.1080/00498250802001826
Metabolism of prazosin in rat and characterization of metabolites in plasma, urine, faeces, brain and bile using liquid chromatography/mass spectrometry (LC/MS).
J. Erve (2008)
10.1016/j.etp.2008.06.006
Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity).
G. Moser (2009)
10.1002/bmc.1141
Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry.
B. Buszewski (2009)
10.1211/jpp/61.01.0007
Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
K. Yang (2009)
10.1021/tx100268g
Metabolism and toxicity of menthofuran in rat liver slices and in rats.
S. C. Khojasteh (2010)
10.1021/tx100226n
Thiol reactivity and its impact on the ciliate toxicity of α,β-unsaturated aldehydes, ketones, and esters.
Alexander Böhme (2010)
10.1124/dmd.109.031781
Hepatobiliary Toxicity of Furan: Identification of Furan Metabolites in Bile of Male F344/N Rats
C. Hamberger (2010)
10.1080/19440040903473332
Development of an analytical method and survey of foods for furan, 2-methylfuran and 3-methylfuran with estimated exposure
A. Becalski (2010)
10.1021/tx9003215
Identification of furan metabolites derived from cysteine-cis-2-butene-1,4-dial-lysine cross-links.
Ding Lu (2010)
10.1177/0192623310368978
Subchronic Oral Toxicity Study of Furan in Fischer-344 Rats
S. Gill (2010)
Evidence of oxidative
G T. (2010)
10.1021/tx200080b
Cytochromes P450 catalyze the reduction of α,β-unsaturated aldehydes.
Immaculate Amunom (2011)
10.1177/0192623311412980
Subchronic Oral Toxicity Study of Furan in B6C3F1 Mice
S. Gill (2011)
10.1016/j.mrgentox.2011.12.011
Genotoxicity of furan in Big Blue rats.
L. McDaniel (2012)
10.1093/toxsci/kfs005
Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity.
S. Moro (2012)
10.2165/11585250-000000000-00000
Grapefruit-Drug Interactions
K. Seden (2012)
Trapping of cis-2
L. A. Gates (2012)



This paper is referenced by
10.1002/0471266949.BMC262
Recent Advances Toward New Small Molecule Therapies for Heart Failure
D. S. St Jean (2021)
10.1039/d1cb00046b
Mechanisms of allosteric and mixed mode aromatase inhibitors
Samson A. Souza (2021)
10.3390/metabo11020097
Untargeted Metabolic Profiling of 4-Fluoro-Furanylfentanyl and Isobutyrylfentanyl in Mouse Hepatocytes and Urine by Means of LC-HRMS
C. Montesano (2021)
10.1007/s11030-020-10158-3
Design, synthesis and SAR of antitubercular benzylpiperazine ureas
Sohal Satish (2021)
10.1007/S00044-021-02740-7
Discovery of N-phenyl-1-(phenylsulfonamido)cyclopropane-1-carboxamide analogs as NLRP3 inflammasome inhibitors
Wanwan Li (2021)
10.3390/ph14070644
Preclinical Studies in Anti-Trypanosomatidae Drug Development
Cintya Perdomo (2021)
10.1007/s11419-020-00560-9
Discovering the major metabolites of the three novel fentanyl analogues 3-methylcrotonylfentanyl, furanylbenzylfentanyl, and 4-fluorocyclopropylbenzylfentanyl for forensic case work
Marianne Skov-Skov Bergh (2021)
10.1039/d0gc03922e
Three-component heteroannulation for tetrasubstituted furan construction enabled by successive defluorination and dual sulfonylation relay
Song-Zhou Cai (2021)
10.1039/d1cc01731d
Furan warheads for covalent trapping of weak protein-protein interactions: cross-linking of thymosin β4 to actin.
Laia Miret-Casals (2021)
10.1016/j.watres.2021.116815
Tube-in-tube membrane photoreactor as a new technology to boost sulfate radical advanced oxidation processes.
E. C. Lumbaque (2021)
10.1021/jacs.0c07077
Toward Drug Release Using Polymer Mechanochemical Disulfide Scission.
Zhiyuan Shi (2020)
10.1021/acs.est.9b04926
Chlorination of Phenols Revisited: Unexpected Formation of α,β-Unsaturated C4-Dicarbonyl Ring Cleavage Products.
C. Prasse (2020)
10.1021/acs.chemrestox.0c00475
Cytochrome P450 Mediated Bioactivation of Rutaevin, a Bioactive and Potentially Hepatotoxic Component of Evodia Rutaecarpa.
Yutao Liu (2020)
10.1002/anie.202012544
Sugar-Based Polymers from D-xylose: Living Cascade Polymerization, Tunable Degradation, and Small Molecule Release.
A. Rizzo (2020)
10.1021/acs.chemrestox.9b00486
Cytochrome P450 Enzyme-Mediated Bioactivation as an Underlying Mechanism of Columbin-Induced Hepatotoxicity.
J. Pei (2020)
10.1055/a-1152-8169
In Vitro and In Vivo Metabolic Activation of Obacunone, A Bioactive and Potentially Hepatotoxic Constituent of Dictamni Cortex.
Xiuzhuang Lang (2020)
10.1021/acs.chemrestox.0c00228
Cytochrome P450 3A4-Mediated Bioactivation and its Role in Nomilin-Induced Hepatotoxicity.
L. Zhang (2020)
10.3389/fmolb.2020.607904
The Volatilomic Footprints of Human HGC-27 and CLS-145 Gastric Cancer Cell Lines
A. Leiherer (2020)
10.1021/acs.chemrestox.0c00017
Evidence for polyamine, biogenic amine, and amino acid adduction resulting from metabolic activation of diosbulbin B.
Z. Zhang (2020)
10.1007/978-3-030-45923-9_12
Role of Furans as EDCs in Metabolic Disorders
S. Muzammil (2020)
10.1021/acs.jmedchem.0c00479
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development.
R. Rej (2020)
10.1021/acs.chemrestox.0c00081
Structure-Based Reactivity Profiles of Reactive Metabolites with Glutathione.
Xiaomei Liu (2020)
10.1080/15376516.2020.1780361
Exploration of the cellular effects of the high-dose, long-term exposure to coffee roasting product furan and its by-product cis-2-butene-1,4-dial on human and rat hepatocytes
J. Teodoro (2020)
10.1101/2020.10.15.340745
Mechanisms of allosteric and mixed mode aromatase inhibitors
Samson A. Souza (2020)
10.1016/j.toxlet.2020.05.004
Cortex dictamni-induced liver injury in mice: The role of P450-mediated metabolic activation of furanoids.
Linyan Huang (2020)
10.3390/catal10070743
Novel Routes in Transformation of Lignocellulosic Biomass to Furan Platform Chemicals: From Pretreatment to Enzyme Catalysis
Grigorios Dedes (2020)
10.1021/acs.chemrestox.0c00170
LC-MS/MS Coupled with a Stable-Isotope Dilution Method for the Quantitation of Thioproline-Glycine: A Novel Metabolite in Formaldehyde- and Oxidative Stress-Exposed Cells.
Guanrui Pan (2020)
10.1016/S1875-5364(20)30005-4
The crucial role of metabolic regulation in differential hepatotoxicity induced by furanoids in Dioscorea bulbifera.
Zi-Tian Wu (2020)
10.1016/j.toxlet.2020.08.002
Urinary metabolites of furan in waterpipe tobacco smokers compared to non-smokers in home settings in the US.
N. Kassem (2020)
10.1007/s11030-020-10049-7
The status of isocyanide-based multi-component reactions in Iran (2010–2018)
A. Shaabani (2020)
10.1021/acs.chemrestox.0c00141
Cytochrome P450-Mediated Bioactivation: Implication for the Liver Injury Induced by Fraxinellone, A Bioactive Constituent from Dictamni Cortex.
Haining Zhou (2020)
Synthesis and SAR Analysis of GATA4- NKX2-5 Interaction Inhibitors with Antihypertrophic Activity
Mikael Jumppanen (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar